Hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region)
Americas (WHO region): Hypertension effective treatment coverage (controlled hypertension) was 36.4% in 2019. ▲ Rising
Hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region), 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region) stood at 36.4%. That is the highest value across all 30 years on record.
That represents a change of up 0.6% on the previous year and up 12.3% over ten years.
Over the whole period, hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region) peaked at 36.4% in 2019 and was at its lowest, 14.8%, in 1990.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 14.8% | — |
| 1991 | 15.3% | +3.4% |
| 1992 | 15.8% | +3.3% |
| 1993 | 16.4% | +3.8% |
| 1994 | 17.1% | +4.3% |
| 1995 | 17.9% | +4.7% |
| 1996 | 18.7% | +4.5% |
| 1997 | 19.6% | +4.8% |
| 1998 | 20.5% | +4.6% |
| 1999 | 21.4% | +4.4% |
| 2000 | 22.3% | +4.2% |
| 2001 | 23.4% | +4.9% |
| 2002 | 24.5% | +4.7% |
| 2003 | 25.7% | +4.9% |
| 2004 | 27.0% | +5.1% |
| 2005 | 28.2% | +4.4% |
| 2006 | 29.4% | +4.3% |
| 2007 | 30.5% | +3.7% |
| 2008 | 31.5% | +3.3% |
| 2009 | 32.4% | +2.9% |
| 2010 | 33.1% | +2.2% |
| 2011 | 33.9% | +2.4% |
| 2012 | 34.5% | +1.8% |
| 2013 | 35.0% | +1.4% |
| 2014 | 35.4% | +1.1% |
| 2015 | 35.7% | +0.8% |
| 2016 | 35.9% | +0.6% |
| 2017 | 36.0% | +0.3% |
| 2018 | 36.2% | +0.6% |
| 2019 | 36.4% | +0.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 17.8% | 14.8% | 21.4% | 10 |
| 2000s | 27.5% | 22.3% | 32.4% | 10 |
| 2010s | 35.2% | 33.1% | 36.4% | 10 |
Countries ranked near Americas (WHO region)
More health data for Americas (WHO region)
- Neonatal tetanus - number of reported cases, gaps filled 23 (2025)
- Pertussis - number of reported cases, gaps filled 24,640 (2025)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Number of neonatal deaths, annual growth rate -3.22 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -20.67 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate -12.7 % change on previous year (2025)
- Measles - number of reported cases 12,380 (2025)
Frequently asked questions
- What is hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region)?
- Hypertension effective treatment coverage (controlled hypertension) in Americas (WHO region) was 36.4% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension effective treatment coverage (controlled hypertension) recorded in Americas (WHO region)?
- The highest recorded value was 36.4% in 2019.
- What is the lowest hypertension effective treatment coverage (controlled hypertension) recorded in Americas (WHO region)?
- The lowest recorded value was 14.8% in 1990.
- How does Americas (WHO region) rank for hypertension effective treatment coverage (controlled hypertension)?
- Americas (WHO region) ranks 1st out of 11 groups with data for 2019.
- Is hypertension effective treatment coverage (controlled hypertension) rising or falling in Americas (WHO region)?
- Over the last ten years it is up 12.3%. The long-run trend across the full record is rising.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).